Eligibility Verification High-Cost Medical Services: The 2025 Revenue Imperative
In 2025, high-volume oncology clinics forfeit $15,000+ per denied chemotherapy infusion from unverified expired coverage per MGMA benchmarks, with eligibility errors fueling 30–40% of front-end denials and inflating A/R beyond 50 days even in streamlined workflows, exposing how payer variability and manual checks hemorrhage 10–41% of claims in high-stakes services like J-codes for oncology drugs, […]









